Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SREBF2 | hg38_v1_chr22_+_41833079_41833142 | 0.08 | 6.7e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.3 | 19.0 | GO:1904603 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
0.9 | 15.8 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
2.3 | 6.9 | GO:0060981 | cell migration involved in coronary angiogenesis(GO:0060981) |
0.9 | 6.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.4 | 4.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 4.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 3.8 | GO:0070206 | protein trimerization(GO:0070206) |
1.1 | 3.4 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.0 | 3.1 | GO:0016266 | glycolipid biosynthetic process(GO:0009247) O-glycan processing(GO:0016266) |
0.2 | 2.8 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 17.9 | GO:0001650 | fibrillar center(GO:0001650) |
0.4 | 15.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 8.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 3.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 3.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 2.6 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 2.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.8 | 2.4 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.1 | 1.0 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.0 | 0.9 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.3 | 19.0 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
0.1 | 17.0 | GO:0097110 | scaffold protein binding(GO:0097110) |
1.7 | 6.9 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
1.3 | 6.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 4.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 4.4 | GO:0005518 | collagen binding(GO:0005518) |
0.6 | 3.1 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.9 | 2.8 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.0 | 2.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.8 | 2.5 | GO:0016420 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 19.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 15.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 7.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 7.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 6.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 3.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 3.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 2.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 2.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 2.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 18.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 6.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 4.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 3.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 2.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 2.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 1.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.7 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |